Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 26, Issue 17, Pages 2883-2889Publisher
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.15.2702
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA058184, P50CA058184] Funding Source: Medline
Ask authors/readers for more resources
Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available